Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features
Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine a dose of the investigational drug betahistine
dihydrochloride that is both well tolerated and potentially effective in treating the
symptoms of atypical depression. Atypical depression is characterized by the ability of the
person's mood to improve temporarily in response to positive events, as well as features such
as increased appetite, increased sleep and severe fatigue.